Your session is about to expire
← Back to Search
Nerve Protector
Interventional for Shoulder Dropped
N/A
Waitlist Available
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
-Any neck dissection (cervical lymphadenectomy) that involves resection of level 2 cervical lymph nodes for malignancy and does not fall into the categories listed under the
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
Summary
The purpose of this study is to determine whether Axoguard nerve protectors have a role in preventing shoulder disability and pain following spinal accessory nerve sparing neck dissections.
Eligible Conditions
- Shoulder Dropped
- Cervical Lymphadenopathy
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~patients will be asked to rate shoulder pain from 1-10 at each postoperative visit over the course of 6 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Shoulder function
Secondary study objectives
Postoperative pain following neck dissection: rate shoulder pain from 1-10
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionalExperimental Treatment1 Intervention
Patients who provide consent for implant placement and do receive the implant.
Group II: ControlPlacebo Group1 Intervention
Patients who provide consent for implant placement but do not receive the implant.
Find a Location
Who is running the clinical trial?
University of Mississippi Medical CenterLead Sponsor
179 Previous Clinical Trials
196,971 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger